Shoulder Innovations (SI) Competitors

LeMaitre Vascular (NASDAQ:LMAT) and Shoulder Innovations (NYSE:SI) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

Does the media prefer LMAT or SI?

In the previous week, Shoulder Innovations had 3 more articles in the media than LeMaitre Vascular. MarketBeat recorded 7 mentions for Shoulder Innovations and 4 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 0.82 beat Shoulder Innovations' score of 0.38 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Shoulder Innovations	0 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more volatility and risk, LMAT or SI?

LeMaitre Vascular has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. Comparatively, Shoulder Innovations has a beta of 2.23, indicating that its share price is 123% more volatile than the S&P 500.

Do institutionals & insiders have more ownership in LMAT or SI?

84.6% of LeMaitre Vascular shares are held by institutional investors. Comparatively, 94.4% of Shoulder Innovations shares are held by institutional investors. 9.5% of LeMaitre Vascular shares are held by company insiders. Comparatively, 1.7% of Shoulder Innovations shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Which has higher valuation and earnings, LMAT or SI?

LeMaitre Vascular has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$226.26M	8.42	$44.04M	$1.98	42.61
Shoulder Innovations	$34.57M	13.14	-$937.91M	-$29.96	-0.48

Is LMAT or SI more profitable?

Shoulder Innovations has a net margin of 45.10% compared to LeMaitre Vascular's net margin of 19.96%. LeMaitre Vascular's return on equity of 13.53% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	19.96%	13.53%	9.78%
Shoulder Innovations	45.10%	8.87%	0.81%

Do analysts rate LMAT or SI?

LeMaitre Vascular currently has a consensus target price of $97.83, indicating a potential upside of 15.97%. Given LeMaitre Vascular's stronger consensus rating and higher probable upside, equities analysts plainly believe LeMaitre Vascular is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Shoulder Innovations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is LMAT or SI a better dividend stock?

LeMaitre Vascular pays an annual dividend of $0.80 per share and has a dividend yield of 0.9%. Shoulder Innovations pays an annual dividend of $2.9420 per share and has a dividend yield of 20.5%. LeMaitre Vascular pays out 40.4% of its earnings in the form of a dividend. Shoulder Innovations pays out -9.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. LeMaitre Vascular has increased its dividend for 14 consecutive years. Shoulder Innovations is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

LeMaitre Vascular beats Shoulder Innovations on 12 of the 19 factors compared between the two stocks.